BioSpace News Archive

Anthem Blue Cross and Blue Shield Will Offer Medicare Advantage Plans in all Indiana Counties for 2019

Anthem plans help consumers improve their health and well-being through high-quality, affordable healthcare services

October 15, 2018
·
6 min read
Genetown

Anthem Blue Cross and Blue Shield Will Offer Medicare Advantage Plans in 13 Maine Counties for 2019

Anthem plans help consumers improve their health and well-being through high-quality, affordable healthcare services

October 15, 2018
·
5 min read
Business

Anthem Blue Cross and Blue Shield Will Offer Medicare Advantage Plans in 6 New Hampshire Counties for 2019

Anthem plans help consumers improve their health and well-being through high-quality, affordable healthcare services

October 15, 2018
·
5 min read
BioMidwest

Anthem Blue Cross and Blue Shield Will Offer Medicare Advantage Plans in all Ohio Counties for 2019

Anthem plans help consumers improve their health and well-being through high-quality, affordable healthcare services

October 15, 2018
·
6 min read
Business

F-star Appoints Dr Eliot Forster as Chief Executive Officer

F-star today announced the appointment of Dr Eliot Forster as Chief Executive Officer. Dr Forster succeeds former CEO Dr John Haurum.

October 15, 2018
·
4 min read
BioCapital

Is It Possible? A Future Where People and Nature Thrive

Can we drive economic growth, meet rising demand for food, energy and water, and make significant environmental progress? The short answer is “yes,” but it comes with several big “ifs.”

October 15, 2018
·
5 min read
Drug Development

Aura Biosciences to Present Phase 1b/2 Clinical Data for AU-011 at the American Academy of Ophthalmology 2018 Annual Meeting

Company Also Selected to Present its First in Class Therapy for the Treatment of Choroidal Melanoma at the Ophthalmology Innovation Summit

October 15, 2018
·
4 min read
Genetown

X4 Pharmaceuticals and Collaborators Present Data that WHIM Syndrome is Underdiagnosed and Patients are Impacted by Broad Spectrum of Medical Complications

Three poster presentations showcased at NORD Rare Disease Summit

October 15, 2018
·
6 min read
FDA

X4 Pharmaceuticals Receives Orphan Drug Designation from the U.S. FDA for X4P-001-RD for the Treatment of WHIM Syndrome

X4 Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for the Company’s drug candidate, X4P-001-RD for the treatment of WHIM syndrome

October 15, 2018
·
3 min read
BioCapital

Anthem Blue Cross and Blue Shield Will Offer Medicare Advantage Plans in 132 Virginia Counties and Cities for 2019

Anthem plans help consumers improve their health and well-being through high-quality, affordable healthcare services

October 15, 2018
·
6 min read